Abstract: The multilevel flying capacitor converter (ML-FCC) has garnered widespread recognition and adoption across various applications over decades. However, achieving an efficiency of ≥99% in the ...
In spite of all this turbulence, three American companies—Slate Auto, Scout Motors (which, to be fair, is a subsidiary of the Volkswagen Group), and Telo Trucks—are standing strong in the melee, ...
Abstract: In this article, a sinusoidal-driven wireless integrated single-phase induction motor system featuring a dual stator-winding structure is introduced. The innovative dual stator-winding ...
We live in interesting times, so all EV owners should have at least one adapter at hand. But which one? Let us explain.
Alteryx, Inc., a leading AI and data analytics company, announced the general availability of Alteryx Copilot and new GenAI-powered tools in the Alteryx One platform. Alteryx's new capabilities help ...
Berlin, Germany, and Research Triangle Park, N.C., USA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Product designation supports development of innovative investigational gene ...
Visually, nothing distinguishes the single-motor EX30 from its dual-motor sibling, the more powerful version costing $6000 more. The single electric motor, rated at 268 hp, is mounted aft and powers ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Israeli Prime Minister Benjamin Netanyahu on ...
Israeli Prime Minister Benjamin Netanyahu said on Sunday that he will meet President Donald Trump later this month, saying a second phase of the U.S. president's Gaza plan was close. The meeting will ...
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...
Less than two months after smashing its own (unofficial) record in power density with its proprietary axial flux motor, YASA has unveiled a real-world application of the technology as an in-wheel ...
A phase 3 trial of Belite Bio’s tinlarebant in adolescents with a rare genetic eye disease has met its primary endpoint, encouraging the biotech to add the U.S. to the list of countries in which it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results